272 related articles for article (PubMed ID: 28932021)
1. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
2. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
3. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
4. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Erfan G; Guzel S; Alpsoy S; Rifaioglu EN; Kaya S; Kucukyalcın V; Topcu B; Kulac M
Mol Cell Biochem; 2015 Feb; 400(1-2):207-12. PubMed ID: 25421412
[TBL] [Abstract][Full Text] [Related]
6. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis, some serum inflammatory markers in psoriasis.
Alpsoy S; Akyuz A; Erfan G; Akkoyun DC; Topcu B; Guzel S; Kaya S; Kulac M
G Ital Dermatol Venereol; 2014 Apr; 149(2):167-75. PubMed ID: 24819636
[TBL] [Abstract][Full Text] [Related]
8. YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis.
Imai Y; Tsuda T; Aochi S; Futatsugi-Yumikura S; Sakaguchi Y; Nakagawa N; Iwatsuki K; Yamanishi K
J Dermatol Sci; 2011 Oct; 64(1):75-7. PubMed ID: 21782391
[No Abstract] [Full Text] [Related]
9. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40 is increased in patients with slow coronary flow.
Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
12. Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Postepy Dermatol Alergol; 2018 Oct; 35(5):485-489. PubMed ID: 30429706
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of YKL-40 are increased in patients with psoriasis: a meta-analysis.
Kong Y; Zhang S; Su X; Peng D; Su Y
Postgrad Med; 2019 Aug; 131(6):405-412. PubMed ID: 31298974
[No Abstract] [Full Text] [Related]
14. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
15. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
16. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
17. Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?
Matusiak Ł; Salomon J; Nowicka-Suszko D; Bieniek A; Szepietowski JC
Acta Derm Venereol; 2015 Jul; 95(6):736-7. PubMed ID: 25655759
[No Abstract] [Full Text] [Related]
18. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
19. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
20. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
